BOSTON: The Global CEO Initiative on Alzheimer’s Disease (CEOi) has developed an innovative research initiative with the potential to bring new evidence and innovation to public and private research agendas aimed at redefining care delivery and changing the way future generations are affected by Alzheimer’s disease.
In collaboration with Optum Labs, the open center for health care research and innovation in Cambridge, Mass., CEOi has launched the “Big Data Research Initiative to Fight Alzheimer’s Disease,” targeted at drawing stakeholders from industry, academia and government agencies to accelerate the pace of Alzheimer’s research for treatments and care. The initiative will generate input from a broad set of collaborators and provide output and insight to other stakeholders and to the public in order to advance the field. CEOi is raising funds to support the research from private sector organizations, foundations supporting Alzheimer’s research and other stakeholders focused on the care and cure of patients with Alzheimer’s disease…